VeriMomhydrogenated tallowamide dea est-il sûr pendant la grossesse ?
No EU Annex II/III listing or harmonised CLP CMR classification was found for CAS 68440-32-4 (ECHA substance records list it as 'fatty acids, tallow, reaction products with diethanolamine' but show no harmonised H‑codes). PubChem and ECHA list the substance as a reaction product/mixture; peer‑reviewed reproductive studies specific to hydrogenated tallowamide DEA were not found. Because it is a fatty‑acid diethanolamide (a surfactant/amphiphile) dermal absorption is possible but expected to be low for typical cosmetic use (hence exposure scored 1). Sources: ECHA substance info, PubChem, CIR draft on DEA-related compounds, EWG ingredient page.
Related ingredients
Frequently asked questions
- hydrogenated tallowamide dea est-il sûr pendant la grossesse ?
- No EU Annex II/III listing or harmonised CLP CMR classification was found for CAS 68440-32-4 (ECHA substance records list it as 'fatty acids, tallow, reaction products with diethanolamine' but show no harmonised H‑codes). PubChem and ECHA list the substance as a reaction product/mixture; peer‑reviewed reproductive studies specific to hydrogenated tallowamide DEA were not found. Because it is a fatty‑acid diethanolamide (a surfactant/amphiphile) dermal absorption is possible but expected to be low for typical cosmetic use (hence exposure scored 1). Sources: ECHA substance info, PubChem, CIR draft on DEA-related compounds, EWG ingredient page.
- hydrogenated tallowamide dea est-il sûr pendant l'allaitement ?
- Same evidence basis as for pregnancy: no harmonised classification or specific reproductive/developmental toxicity data were located for this CAS. Theoretical class concerns about DEA‑type substances (e.g., formation of nitrosamines or residual free DEA) are noted in broader DEA discussions but are not specific toxicological proof for this substance. Dermal exposure from cosmetics is low‑to‑measurable; breastfeeding exposure via milk is not demonstrated in the literature for this ingredient.
- hydrogenated tallowamide dea est-il sûr pour la peau de bébé ?
- No infant‑specific reproductive or developmental data were identified. Infant skin has higher surface‑area‑to‑weight and immature barrier function, so exposure score is increased by +1 relative to adult (adult e=1 → infant e=2) despite lack of data showing systemic effects. No evidence found that the ingredient is banned/restricted for infant use under EU Cosmetic Regulation.
- Comment VeriMom évalue-t-il hydrogenated tallowamide dea ?
- VeriMom évalue hydrogenated tallowamide dea à 93/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à hydrogenated tallowamide dea pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à hydrogenated tallowamide dea basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.